EAM Global Investors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,177
Closed -$747K 159
2020
Q1
$747K Buy
5,177
+652
+14% +$94.1K 0.44% 93
2019
Q4
$925K Sell
4,525
-7,302
-62% -$1.49M 0.37% 108
2019
Q3
$950K Sell
11,827
-10,030
-46% -$806K 0.46% 99
2019
Q2
$2.06M Sell
21,857
-5,198
-19% -$490K 0.88% 32
2019
Q1
$2.31M Buy
27,055
+3,488
+15% +$298K 1.02% 19
2018
Q4
$1.32M Sell
23,567
-3,954
-14% -$222K 0.72% 71
2018
Q3
$2.25M Buy
+27,521
New +$2.25M 0.91% 19